|
|
|
Insider
Information: |
Novartis Ag |
Relationship: |
10% Owner |
City: |
Basel Switzerland |
State: |
V8 |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
20 |
|
Direct
Shares |
49,437,478 |
|
Indirect Shares
|
22,159,174 |
|
|
Direct
Value |
$481,385,768 |
|
|
Indirect Value
|
$313,535,707 |
|
|
Total
Shares |
71,596,652 |
|
|
Total
Value |
$794,921,475 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
14
|
Stock
price went up :
|
0
|
14
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
14.0
|
Percentage
Gain/Loss : |
0.0%
|
273.2%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Momenta Pharmaceuticals Inc |
MNTA |
10% Owner |
|
0 |
2006-07-25 |
4,708,679 |
Premium* |
|
Adhera Therapeutics, Inc |
ATRX |
10% Owner |
2011-01-26 |
2,495,065 |
|
0 |
Premium* |
|
Idenix Pharmaceuticals Inc |
IDIX |
10% Owner |
2014-08-05 |
0 |
2014-08-05 |
0 |
Premium* |
|
Eledon Pharmaceuticals Ord Shs |
ELDN |
10% Owner |
2015-07-15 |
4,493,458 |
2014-09-22 |
0 |
Premium* |
|
Kineta Ord Shs |
KA |
10% Owner |
2016-02-17 |
1,873,791 |
2016-02-17 |
0 |
Premium* |
|
Aeglea Biotherapeutics, Inc. |
AGLE |
|
2018-05-11 |
2,175,314 |
2016-04-12 |
0 |
Premium* |
|
Intellia Therapeutics, Inc. |
NTLA |
10% Owner |
2017-12-12 |
4,129,903 |
2016-05-11 |
0 |
Premium* |
|
Q32 Bio Inc |
QTTB |
10% Owner |
2018-04-02 |
1,979,226 |
2018-04-02 |
0 |
Premium* |
|
Ra Pharmaceuticals, Inc. |
RARX |
10% Owner |
2017-06-19 |
2,251,457 |
2016-10-31 |
0 |
Premium* |
|
Aadi Bioscience, Inc |
AADI |
10% Owner |
2017-03-15 |
0 |
2019-04-26 |
4,049,804 |
Premium* |
|
Altimmune, Inc |
ALT |
10% Owner |
|
0 |
2018-09-12 |
8,345,145 |
Premium* |
|
Surface Oncology, Inc. |
SURF |
10% Owner |
2018-04-23 |
3,948,482 |
2018-04-23 |
0 |
Premium* |
|
Aileron Therapeutics Inc |
ALRN |
10% Owner |
2019-04-01 |
2,079,394 |
2018-07-16 |
0 |
Premium* |
|
Bicycle Therapeutics Ltd |
BCYC |
10% Owner |
2019-05-28 |
1,769,641 |
2019-05-28 |
0 |
Premium* |
|
Galera Therapeutics, Inc. |
GRTX |
Former 10% Owner |
2020-06-19 |
2,467,961 |
2019-11-12 |
3,543,067 |
Premium* |
|
Forma Therapeutics Holdings, Inc., |
FMTX |
10% Owner |
|
0 |
2020-06-18 |
331,221 |
Premium* |
|
Akouos, Inc. |
AKUS |
Former 10% Owner |
2020-06-30 |
0 |
2020-06-30 |
1,181,258 |
Premium* |
|
Poseida Therapeutics, Inc. |
PSTX |
10% Owner |
2020-07-14 |
5,908,089 |
2020-07-14 |
0 |
Premium* |
|
Cellular Biomedicine Group Inc |
CBMG |
10% Owner |
2020-08-11 |
1,458,257 |
|
0 |
Premium* |
|
Precision Biosciences Inc |
DTIL |
10% Owner |
2022-06-15 |
12,407,440 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
152 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 5 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ALRN |
Aileron Therapeutics Inc |
10% Owner |
|
2018-08-16 |
4 |
S |
$2.10 |
$18,497 |
D/D |
(8,808) |
2,425,970 |
0 |
- |
|
ALRN |
Aileron Therapeutics Inc |
10% Owner |
|
2018-08-17 |
4 |
S |
$2.10 |
$18,270 |
D/D |
(8,700) |
2,417,270 |
0 |
- |
|
ALRN |
Aileron Therapeutics Inc |
10% Owner |
|
2018-08-20 |
4 |
S |
$2.30 |
$46,892 |
D/D |
(20,388) |
2,396,882 |
0 |
- |
|
AADI |
Aadi Bioscience, Inc |
10% Owner |
|
2018-08-20 |
4 |
S |
$3.90 |
$20,670 |
I/I |
(5,300) |
5,800,250 |
0 |
- |
|
ALT |
Altimmune, Inc |
10% Owner |
|
2018-09-12 |
4 |
A |
$0.00 |
$0 |
I/I |
2,069,993 |
8,345,145 |
0 |
- |
|
ALRN |
Aileron Therapeutics Inc |
10% Owner |
|
2019-03-13 |
4 |
S |
$2.12 |
$281,405 |
D/D |
(132,738) |
2,264,144 |
0 |
- |
|
ALRN |
Aileron Therapeutics Inc |
10% Owner |
|
2019-03-14 |
4 |
S |
$1.88 |
$25,944 |
D/D |
(13,800) |
2,250,344 |
0 |
- |
|
ALRN |
Aileron Therapeutics Inc |
10% Owner |
|
2019-03-15 |
4 |
S |
$1.92 |
$84,096 |
D/D |
(43,800) |
2,206,544 |
0 |
- |
|
AADI |
Aadi Bioscience, Inc |
10% Owner |
|
2019-03-26 |
4 |
S |
$1.01 |
$179,540 |
I/I |
(177,762) |
5,622,488 |
0 |
- |
|
AADI |
Aadi Bioscience, Inc |
10% Owner |
|
2019-03-27 |
4 |
S |
$0.99 |
$50,242 |
I/I |
(50,749) |
5,571,739 |
0 |
- |
|
AADI |
Aadi Bioscience, Inc |
10% Owner |
|
2019-03-28 |
4 |
S |
$0.94 |
$83,505 |
I/I |
(88,835) |
5,482,904 |
0 |
- |
|
AADI |
Aadi Bioscience, Inc |
10% Owner |
|
2019-03-29 |
4 |
S |
$0.91 |
$57,421 |
I/I |
(63,100) |
5,419,804 |
0 |
- |
|
ALRN |
Aileron Therapeutics Inc |
10% Owner |
|
2019-03-29 |
4 |
S |
$1.85 |
$197,099 |
D/D |
(106,540) |
2,100,004 |
0 |
- |
|
AADI |
Aadi Bioscience, Inc |
10% Owner |
|
2019-04-01 |
4 |
S |
$0.95 |
$111,064 |
I/I |
(116,909) |
5,302,895 |
0 |
- |
|
ALRN |
Aileron Therapeutics Inc |
10% Owner |
|
2019-04-01 |
4 |
S |
$1.90 |
$39,159 |
D/D |
(20,610) |
2,079,394 |
0 |
- |
|
AADI |
Aadi Bioscience, Inc |
10% Owner |
|
2019-04-02 |
4 |
S |
$0.97 |
$50,201 |
I/I |
(51,754) |
5,251,141 |
0 |
- |
|
AADI |
Aadi Bioscience, Inc |
10% Owner |
|
2019-04-03 |
4 |
S |
$0.96 |
$55,712 |
I/I |
(58,033) |
5,193,108 |
0 |
- |
|
AADI |
Aadi Bioscience, Inc |
10% Owner |
|
2019-04-04 |
4 |
S |
$1.01 |
$48,379 |
I/I |
(47,900) |
5,145,208 |
0 |
- |
|
AADI |
Aadi Bioscience, Inc |
10% Owner |
|
2019-04-05 |
4 |
S |
$1.02 |
$25,154 |
I/I |
(24,661) |
5,120,547 |
0 |
- |
|
AADI |
Aadi Bioscience, Inc |
10% Owner |
|
2019-04-08 |
4 |
S |
$1.02 |
$28,076 |
I/I |
(27,525) |
5,093,022 |
0 |
- |
|
AADI |
Aadi Bioscience, Inc |
10% Owner |
|
2019-04-09 |
4 |
S |
$1.01 |
$33,321 |
I/I |
(32,991) |
5,060,031 |
0 |
- |
|
AADI |
Aadi Bioscience, Inc |
10% Owner |
|
2019-04-10 |
4 |
S |
$1.09 |
$152,851 |
I/I |
(140,230) |
4,919,801 |
0 |
- |
|
AADI |
Aadi Bioscience, Inc |
10% Owner |
|
2019-04-11 |
4 |
S |
$1.08 |
$62,033 |
I/I |
(57,438) |
4,862,363 |
0 |
- |
|
AADI |
Aadi Bioscience, Inc |
10% Owner |
|
2019-04-12 |
4 |
S |
$1.04 |
$32,144 |
I/I |
(30,908) |
4,831,455 |
0 |
- |
|
AADI |
Aadi Bioscience, Inc |
10% Owner |
|
2019-04-15 |
4 |
S |
$0.99 |
$28,506 |
I/I |
(28,794) |
4,802,661 |
0 |
- |
|
152 Records found
|
|
Page 5 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|